<!doctype html><html lang=en-us><head><title>OMSF</title><meta charset=utf-8><meta name=viewport content="width=device-width,initial-scale=1"><meta name=description content="The HTML5 Herald"><meta name=author content><meta property="og:title" content="People"><meta property="og:description" content="Board of Directors  David L. Mobley President, Co-Founder Twitter | Linkedin | Web University of California, Irvine
Prof. David Mobley holds a joint appointment in the Pharmaceutical Sciences and Department of Chemistry at the University of California, Irvine. A major focus of his research is the binding of small-molecule ligands to proteins, including development, application and validation of binding free energy methods. He's currently spearheading the SAMPL challenges and co-leading the Open Force Field Initiative."><meta property="og:type" content="article"><meta property="og:url" content="https://omsf.io/about/people/"><meta property="article:section" content="about"><meta name=twitter:card content="summary"><meta name=twitter:title content="People"><meta name=twitter:description content="Board of Directors  David L. Mobley President, Co-Founder Twitter | Linkedin | Web University of California, Irvine
Prof. David Mobley holds a joint appointment in the Pharmaceutical Sciences and Department of Chemistry at the University of California, Irvine. A major focus of his research is the binding of small-molecule ligands to proteins, including development, application and validation of binding free energy methods. He's currently spearheading the SAMPL challenges and co-leading the Open Force Field Initiative."><meta name=generator content="Hugo 0.85.0"><link rel=stylesheet href=https://cdnjs.cloudflare.com/ajax/libs/normalize/8.0.1/normalize.min.css integrity="sha256-l85OmPOjvil/SOvVt3HnSSjzF1TUMyT9eV0c2BzEGzU=" crossorigin=anonymous><link rel=stylesheet href=https://omsf.io/fontawesome/css/all.min.css><link rel=preconnect href=https://fonts.googleapis.com><link rel=preconnect href=https://fonts.gstatic.com crossorigin><link href="https://fonts.googleapis.com/css2?family=Barlow:wght@400;600;700;900&display=swap" rel=stylesheet><link rel=stylesheet type=text/css href=/css/style.css><link rel=apple-touch-icon sizes=180x180 href=/apple-touch-icon.png><link rel=icon type=image/png sizes=32x32 href=/favicon-32x32.png><link rel=icon type=image/png sizes=16x16 href=/favicon-16x16.png><link rel=manifest href=/site.webmanifest><meta name=msapplication-TileColor content="#da532c"><meta name=theme-color content="#ffffff"><script type=text/javascript>var _paq=window._paq=window._paq||[];_paq.push(['trackPageView']),_paq.push(['enableLinkTracking']),function(){var d="https://omsf.matomo.cloud/",b,a,c;_paq.push(['setTrackerUrl',d+'matomo.php']),_paq.push(['setSiteId','1']),b=document,a=b.createElement('script'),c=b.getElementsByTagName('script')[0],a.type='text/javascript',a.async=!0,a.src='//cdn.matomo.cloud/omsf.matomo.cloud/matomo.js',c.parentNode.insertBefore(a,c)}()</script></head><body><div id=container><header><a class=logo href=/><img src=/images/logo-web.png alt=OMSF></a><nav><ul><li><a class=active href=/about/mission>About</a></li><li><a href=/services/fiscal-sponsorship/>Services</a></li><li><a href=/projects/host-project>Projects</a></li><li><a href=/support/how-to>Support</a></li></ul></nav><button onclick=myFunction() id=toggle-main-menu-mobile class="hamburger hamburger--slider" type=button>
<span class=hamburger-box><span class=hamburger-inner></span></span></button><div id=mobile-submenu style=display:none class=mobile-submenu><a class=active href=/about/mission>About</a>
<a href=/services/fiscal-sponsorship/>Services</a>
<a href=/projects/host-project>Projects</a>
<a href=/support/how-to>Support</a></div><script>function myFunction(){var a=document.getElementById("mobile-submenu");a.style.display==="none"?a.style.display="block":a.style.display="none"}</script></header><main><div class=sub-wrapper><div class=sub><a href=/about/mission/><span>Mission</span></a>
<a class=active href=/about/people/><span>People</span></a>
<a href=/about/careers/><span>Careers</span></a>
<a href=/about/legal/><span>Documents</span></a></div></div><article><h1>People</h1><div class=header-two><img src=/OMSF/images/H2before.png alt><h2 id=board-of-directors>Board of Directors</h2></div><div class=image><p><img src=/images/davidlmobley.jpg alt="David L. Mobley">
<strong>David L. Mobley</strong>
<em>President, Co-Founder</em>
<a href=https://twitter.com/davidlmobley>Twitter</a> | <a href=https://www.linkedin.com/in/david-mobley-1b09724>Linkedin</a> | <a href=https://mobleylab.org/>Web</a>
<em>University of California, Irvine</em></p><p>Prof. David Mobley holds a joint appointment in the Pharmaceutical Sciences and Department of Chemistry at the University of California, Irvine. A major focus of his research is the binding of small-molecule ligands to proteins, including development, application and validation of binding free energy methods. He's currently spearheading the <a href=https://www.samplchallenges.org/>SAMPL challenges</a> and co-leading the <a href=http://openforcefield.org/>Open Force Field Initiative</a>. He also serves on the editorial boards of the Journal of Computer-Aided Molecular Design and the Journal of Molecular Recognition, on the scientific advisory board for OpenEye Scientific Software, as a founding and managing editor for the <a href=http://livecomsjournal.org/>Living Journal of Computational Molecular Science</a>, and as an Open Science Fellow for Silicon Therapeutics. David is a strong proponent of open science and currently serves as the President of the Board.</p></div><div class=image><p><img src=/images/karmen.jpg alt="Karmen Condic-Jurkic">
<strong>Karmen Čondić-Jurkić</strong>
<em>Executive Director, Co-Founder</em>
<a href=http://twitter.com/karmecon>Twitter</a> | <a href=http://linkedin.com/in/karmen-condic-jurkic-805073b>LinkedIn</a>
<em>Open Molecular Software Foundation</em></p><p>Karmen Condic-Jurkic is the Executive Director of the Open Molecular Software Foundation. She also currently serves as the Board&rsquo;s Treasurer and Secretary. Karmen holds a PhD in computational chemistry and her research included application of quantum chemistry and molecular dynamics methods on biomolecular systems. During her postdoc years, she developed a passion for open science and got a small grant to build a cloud-based <a href=http://web.archive.org/web/20190228174834/http:/www.mdbox.org/>repository prototype</a> for molecular dynamics trajectories. This work sparked further interest in knowledge management and research infrastructure, including how to make it more open, more robust and more sustainable. She joined the <a href=http://openforcefield.org/>Open Force Field Initiative</a> as a project manager in 2019, and became the OMSF Executive Director in 2021.</p></div><div class=image><p><img src=/images/michaelkgilson.jpg alt="Michael K. Gilson">
<strong>Michael K. Gilson</strong>
<em>Co-Founder</em>
<a href=http://twitter.com/michaelkgilson>Twitter</a> | <a href=http://linkedin.com/in/mkgilson>LinkedIn</a> | <a href=http://gilson.cloud.ucsd.edu/>Web</a>
<em>University of California, San Diego</em></p><p>Mike Gilson, MD, PhD, is Professor and Chair in Computer-Aided Drug Design at the <a href=https://pharmacy.ucsd.edu/>Skaggs School of Pharmacy and Pharmaceutical Sciences</a> and co-director of the <a href=http://drugdiscovery.ucsd.edu/>Center for Drug Discovery Innovation</a> at the <a href=https://ucsd.edu/>University of California San Diego'</a>. He is also a member of the Executive Committee of the <a href=https://www.ucdrugdiscovery.org/>UC Drug Discovery Consortium</a>. A central theme of his research groups is advancing the technologies of computer-aided drug design (CADD), including protein-ligand binding thermodynamics, and force field development and validation. He founded <a href=http://www.bindingdb.org/bind/index.jsp>BindingDB</a>, a public, web-accessible medicinal chemistry database, and co-directed the <a href=https://drugdesigndata.org/>Drug Design Data Resource</a> (D3R), which aimed to advance the technology of computer-aided drug discovery through the interchange of high quality protein-ligand datasets and workflows, and by holding community-wide, blinded prediction challenges. Mike is also one of the PIs leading the <a href=http://openforcefield.org/>Open Force Field Initiative</a> and serves on Editorial Advisory Boards of several journals. Mike has a long history of contributing to molecular sciences and following open science principles.</p></div></article></main><footer class=footer-blue><div class="column-1 column"><img class=logo-footer src=/images/logo-white.png><p>Unless otherwise noted, all content is licensed under the <a style=text-decoration:underline href=https://creativecommons.org/licenses/by/4.0/>CC BY 4.0 license.</a></p></div><div class="column-2 column"><a href=/about/mission>About</a><br><a href=/services/fiscal-sponsorship/>Services</a><br><a href=/projects/host-project>Projects</a><br><a href=/support/how-to>Support</a><br></div><div class="column-3 column"><a href=https://twitter.com/openmsf><img class=logo-footer src=/images/twitter-icon.png></a>
<a href=mailto:info@omsf.io><img class=logo-footer src=/images/mail-icon.png></a>
<a href=https://www.linkedin.com/company/><img class=logo-footer src=/images/linkedin-icon.png></a></div><div class="column-4 column"><a href=/privacy-policy>Privacy Policy</a><br><a href=/bylaws>Bylaws</a><br><a href=/good-standing-policy>Good Standing Policy</a><br><a href=/antitrust-policy>Antitrust Policy</a></div></footer></div></body></html>